相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation
Detmar Kolijn et al.
CARDIOVASCULAR RESEARCH (2021)
Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients
Atsunori Kashiwagi et al.
JOURNAL OF DIABETES INVESTIGATION (2021)
Biomarker-Based Risk Prediction of Incident Heart Failure in Pre-Diabetes and Diabetes
Ambarish Pandey et al.
JACC-HEART FAILURE (2021)
Growth Differentiation Factor (GDF)-15 and Cardiometabolic Outcomes among Older Adults: The Atherosclerosis Risk in Communities Study
Justin B. Echouffo-Tcheugui et al.
CLINICAL CHEMISTRY (2021)
The diagnostic and prognostic value of galectin-3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST-CHF study
Tobias Daniel Trippel et al.
ESC HEART FAILURE (2021)
Diagnostic value of novel biomarkers for heart failure A meta-analysis
Z. Huang et al.
HERZ (2020)
sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure
Manon Barutaut et al.
ACTA CARDIOLOGICA (2020)
Reprint of The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking
Arantxa Gonzalez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
sST2 as a value-added biomarker in heart failure
Manuela Lotierzo et al.
CLINICA CHIMICA ACTA (2020)
N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA])
Khoa Nguyen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Rapid and sensitive detection of interleukin-6 in serum via time-resolved lateral flow immunoassay
Dezhi Huang et al.
ANALYTICAL BIOCHEMISTRY (2020)
How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes? Completed and Ongoing Mechanistic Trials
Matthew M. Y. Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Positive Association Between Serum Levels of High-Sensitivity C-Reactive Protein and Depression/Anxiety in Female, but Not Male, Patients With Type 2 Diabetes Mellitus
Qian-Qian Yang et al.
BIOLOGICAL RESEARCH FOR NURSING (2020)
Highly sensitive vertical flow based point-of-care immunokit for rapid and early detection of human CRP as a cardiovascular risk factor
Anjani Prajapati et al.
BIOMEDICAL MICRODEVICES (2020)
Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial
Abhinav Sharma et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4
Javier Díez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification-A Narrative Review
Alexander E. Berezin et al.
DIABETES THERAPY (2020)
Cardiac natriuretic peptides
Jens P. Goetze et al.
NATURE REVIEWS CARDIOLOGY (2020)
Early Stages of Obesity-related Heart Failure Are Associated with Natriuretic Peptide Deficiency and an Overall Lack of Neurohormonal Activation: The Copenhagen Heart Failure Risk Study
Freja Stoltze Gaborit et al.
GLOBAL HEART (2020)
The relationship between atherosclerosis and bone mineral density in patients with type 2 diabetes depends on vascular calcifications and sex
R. Cui et al.
OSTEOPOROSIS INTERNATIONAL (2020)
The impact of the glucagon-like peptide-1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes
Roni Nielsen et al.
DIABETES OBESITY & METABOLISM (2020)
Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study
David Thein et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Heart Failure With Reduced Ejection Fraction A Review
Sean P. Murphy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure
Alexander E. Berezin et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy
Albert Topf et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus
Alexander E. Berezin et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Exploring collagen remodeling and regulation as prognosis biomarkers in stable heart failure
Anne Marie Dupuy et al.
CLINICA CHIMICA ACTA (2019)
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
Eri T. Kato et al.
CIRCULATION (2019)
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan The PARADIGM-HF Trial
Peder Langeland Myhre et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Changes in Titin and Collagen Modulate Effects of Aerobic and Resistance Exercise on Diabetic Cardiac Function
Shunchang Li et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2019)
Epidemiology of Diabetes Mellitus and Cardiovascular Disease
Diana Glovaci et al.
CURRENT CARDIOLOGY REPORTS (2019)
Diabetic Cardiomyopathy What Is It and Can It Be Fixed?
Wolfgang H. Dillmann
CIRCULATION RESEARCH (2019)
The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study
George Markousis-Mavrogenis et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation
Susana Ravassa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Altered signature of apoptotic endothelial cell-derived microvesicles predicts chronic heart failure phenotypes
Alexander E. Berezin et al.
BIOMARKERS IN MEDICINE (2019)
High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study
Xiaoming Jia et al.
CIRCULATION (2019)
Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study
Evangelos Oikonomou et al.
CURRENT VASCULAR PHARMACOLOGY (2019)
Biomarkers in heart failure: the past, current and future
Michael Sarhene et al.
HEART FAILURE REVIEWS (2019)
Point-of-care testing in primary care: A systematic review on implementation aspects addressed in test evaluations
Deon Lingervelder et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2019)
Association of Galectin-3 With Diabetes Mellitus in the Dallas Heart Study
Amy Vora et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Glucose Metabolism Abnormalities in Heart Failure Patients Insights and Prognostic Relevance
Fabio Marsico et al.
HEART FAILURE CLINICS (2019)
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction The DEFINE-HF Trial
Michael E. Nassif et al.
CIRCULATION (2019)
Galectin-3: is this member of a large family of multifunctional lectins (already) a therapeutic target?
Antonio Romero et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Diabetes, heart failure, and renal dysfunction: The vicious circles
Eugene Braunwald
PROGRESS IN CARDIOVASCULAR DISEASES (2019)
Clinical and Prognostic Significance of sST2 in Heart Failure JACC Review Topic of the Week
Alberto Aimo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis
Hong-Kun Wu et al.
CIRCULATION (2019)
Heart Failure in Type 2 Diabetes Mellitus Impact of Glucose-Lowering Agents, Heart Failure Therapies, and Novel Therapeutic Strategies
Helena C. Kenny et al.
CIRCULATION RESEARCH (2019)
The role of galectin-3 in heart failure and cardiovascular disease
Xiao Zhong et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2019)
Galectin-3 and risk of cardiovascular events and all-cause mortality in type 2 diabetes
Kathryn C. B. Tan et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes
Rasmus Rorth et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation Mechanistic Insights and Clinical Implications
Ernesto Martinez-Martinez et al.
HYPERTENSION (2019)
Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus A Critical Evaluation of Clinical and Regulatory Issues
Javed Butler et al.
CIRCULATION (2019)
C-reactive protein decrease associates with mortality reduction only in heart failure with preserved ejection fraction
Patricia Lourenco et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2019)
Potential biomarkers for heart failure
Che Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Endogenous vascular repair system in cardiovascular disease: The role of endothelial progenitor cells
Alexander E. Berezin
AUSTRALASIAN MEDICAL JOURNAL (2019)
Diabetic cardiomyopathy: acute and reversible left ventricular systolic dysfunction due to cardiotoxicity of hyperglycaemic hyperosmolar state-a case report
Umut Kocabas et al.
EUROPEAN HEART JOURNAL-CASE REPORTS (2019)
Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design
Danish Ali et al.
BMJ OPEN (2019)
The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking
Arantxa Gonzalez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Predictive value of high sensitivity C-reactive protein on progression to heart failure occurring after the first myocardial infarction
Zohair A. Al Aseri et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2019)
Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy
Rui Dong et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Comparison of rapid MMP-8 and interleukin-6 point-of-care tests to identify intra-amniotic inflammation/infection and impending preterm delivery in patients with preterm labor and intact membranes
Piya Chaemsaithong et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2018)
Interleukin-6 Family Cytokines
Stefan Rose-John
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Serum high-sensitive C-reactive protein is associated with dietary intakes in diabetic patients with and without hypertension: a cross-sectional study
Mohammad Bagherniya et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2018)
GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD
Courtney Tuegel et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Baseline High-Sensitivity C-Reactive Protein Predicts Macrovascular and Microvascular Complications of Type 2 Diabetes: A Population-Based Study
Zahra Aryan et al.
ANNALS OF NUTRITION AND METABOLISM (2018)
Cardiovascular Effects of New Oral Glucose-Lowering Agents DPP-4 and SGLT-2 Inhibitors
Andre J. Scheen
CIRCULATION RESEARCH (2018)
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Guanghong Jia et al.
CIRCULATION RESEARCH (2018)
Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial
Petr Jarolim et al.
DIABETES CARE (2018)
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
N. H. Cho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus
Kathryn C. B. Tan et al.
DIABETOLOGIA (2018)
Redefining biomarkers in heart failure
Michele Correale et al.
HEART FAILURE REVIEWS (2018)
Heart failure and inflammation-related biomarkers as predictors of new-onset diabetes in the general population
Navin Suthahar et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Salvatore Sciacchitano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
High-sensitivity C-reactive protein, low-grade systemic inflammation and type 2 diabetes mellitus: A two-sample Mendelian randomization study
R. Noordam et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2018)
Longitudinal evaluation of ventricular ejection fraction and NT-proBNP across heart failure subgroups
Andreas Martinsson et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2018)
Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
Navin Suthahar et al.
THERANOSTICS (2018)
Galectin-3 in Heart Failure An Update of the Last 3 Years
Carolin Gehlken et al.
HEART FAILURE CLINICS (2018)
Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi-Ethnic Study of Atherosclerosis)
Daniel A. Duprez et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Established and Emerging Roles of Biomarkers in Heart Failure
Nasrien E. Ibrahim et al.
CIRCULATION RESEARCH (2018)
High-sensitivity C-reactive protein in heart failure with preserved ejection fraction
Hilary M. DuBrock et al.
PLOS ONE (2018)
Comparison of multiple biomarkers for mortality prediction in patients with acute heart failure of ischemic and nonischemic etiology
Mingliang Zhang et al.
BIOMARKERS IN MEDICINE (2018)
Hypoglycemia and Elevated Troponin in Patients With Diabetes and Coronary Artery Disease
Paulo C. Rezende et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
sST2 Predicts Outcome in Chronic Heart Failure Beyond N-proBNP and High-Sensitivity Troponin T
Michele Emdin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction
Maelle Plawecki et al.
MEDIATORS OF INFLAMMATION (2018)
Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study
Hans-Dirk Duengen et al.
ESC HEART FAILURE (2018)
Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction
Anan Huang et al.
ACTA CARDIOLOGICA (2018)
Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction
Leo F. Buckley et al.
ESC HEART FAILURE (2018)
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
Kai C. Wollert et al.
CLINICAL CHEMISTRY (2017)
A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failure
Michael Lichtenauer et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2017)
An Elevated High-Sensitivity C-Reactive Protein Level Is Associated with Unfavorable Functional Outcomes of Small-Artery Occlusion in Patients without Diabetes
Yuan Gao et al.
EUROPEAN NEUROLOGY (2017)
Insulin receptor substrate signaling controls cardiac energy metabolism and heart failure
Cathy A. Guo et al.
JOURNAL OF ENDOCRINOLOGY (2017)
High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants
Peter Willeit et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case-control study nested within the Singapore Chinese Health Study
An Pan et al.
BMC ENDOCRINE DISORDERS (2017)
Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
Emil Wolsk et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Diabetic cardiomyopathy: where we are and where we are going
Wang-Soo Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2017)
New Insights into Adipokines as Potential Biomarkers for Type-2 Diabetes Mellitus
Marta Olivera-Santa Catalina et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Using biomarkers to guide heart failure management
Kay-Won Chang et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2017)
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials
Yuliya Lytvyn et al.
CIRCULATION (2017)
Circulating Biomarkers of Collagen Metabolism and Prognosis of Heart Failure with Reduced or Mid-Range Ejection Fraction
Joana Moura Ferreira et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Relationship of High-Sensitivity C-Reactive Protein Concentrations and Systolic Heart Failure
Sheng Kang et al.
CURRENT VASCULAR PHARMACOLOGY (2017)
Diabetes Mellitus and Heart Failure
Michael Lehrke et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure A Scientific Statement From the American Heart Association
Sheryl L. Chow et al.
CIRCULATION (2017)
Immunoanalytical characteristics of C-reactive protein and high sensitivity C-reactive protein
Mariame Moutachakkir et al.
ANNALES DE BIOLOGIE CLINIQUE (2017)
The differences in the relationship between diastolic dysfunction, selected biomarkers and collagen turn-over in heart failure patients with preserved and reduced ejection fraction
Blazej Michalski et al.
CARDIOLOGY JOURNAL (2017)
Testing for Soluble ST2 in Heart Failure Patients: Reliability of a Point of Care Method
Damien Gruson et al.
CLINICAL LABORATORY (2017)
Using the galectin-3 test to predict mortality in heart failure patients: a systematic review and meta-analysis
Yueh-Sheng Chen et al.
BIOMARKERS IN MEDICINE (2016)
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study
Michael R. Zile et al.
CIRCULATION-HEART FAILURE (2016)
Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure
Thomas Mueller et al.
CLINICA CHIMICA ACTA (2016)
Clinical relevance of sST2 in cardiac diseases
Domingo A. Pascual-Figal et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity
Cedric Moro
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Characteristic adaptations of the extracellular matrix in dilated cardiomyopathy
Laura Louzao-Martinez et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure
Michael R. Zile et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Epidemiology and aetiology of heart failure
Boback Ziaeian et al.
NATURE REVIEWS CARDIOLOGY (2016)
Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment
Jin Yang et al.
NATURE COMMUNICATIONS (2016)
Galectin-3 in Patients with Acute Heart Failure: Preliminary Report on First Polish Experience
Grazyna Sygitowicz et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2016)
SGLT-2 receptor inhibitors for treating patients with type 2 diabetes mellitus: a systematic review and network meta-analysis
Deepson S Shyangdan et al.
BMJ Open (2016)
Association between hs-CRP Levels and the Outcomes of Patients with Small-Artery Occlusion
Ruiying Qiu et al.
Frontiers in Aging Neuroscience (2016)
Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15
Alexander E. Berezin
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2016)
Autophagic adaptations in diabetic cardiomyopathy differ between type 1 and type 2 diabetes
Hiromitsu Kanamori et al.
AUTOPHAGY (2015)
Upregulation of MG53 Induces Diabetic Cardiomyopathy Through Transcriptional Activation of Peroxisome Proliferation-Activated Receptor α
Fenghua Liu et al.
CIRCULATION (2015)
Analytical and clinical evaluation of a rapid quantitative lateral flow immunoassay for measurement of soluble ST2 in human plasma
Benjamin Dieplinger et al.
CLINICA CHIMICA ACTA (2015)
Markers of fibrosis, inflammation, and remodeling pathways in heart failure
Claudio Passino et al.
CLINICA CHIMICA ACTA (2015)
Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction
Carolyn S. P. Lam
DIABETES & VASCULAR DISEASE RESEARCH (2015)
Prognosis of new-onset heart failure outpatients and collagen biomarkers
Laura Sanchis et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
The Influence of Diabetes Mellitus on Midregional Proadrenomedullin Concentrations and Prognostic Value in Heart Failure Outpatients
Pernille Holmager et al.
JOURNAL OF CARDIAC FAILURE (2015)
What a difference a CRP makes. A prospective observational study on how point-of-care C-reactive protein testing influences antibiotic prescription for respiratory tract infections in Swedish primary health care
Johan Lindstrom et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2015)
Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls?
Anne Pernille Ofstad et al.
JOURNAL OF DIABETES (2015)
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective
Ramu Adela et al.
JOURNAL OF DIABETES RESEARCH (2015)
A point of care test for the determination of amniotic fluid interleukin-6 and the chemokine CXCL-10/IP-10
Piya Chaemsaithong et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2015)
Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?
Varsha Srivatsan et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
Activation of Foxo1 by Insulin Resistance Promotes Cardiac Dysfunction and beta-Myosin Heavy Chain Gene Expression
Yajuan Qi et al.
CIRCULATION-HEART FAILURE (2015)
Growth Differentiation Factor-15 Is a Useful Prognostic Marker in Patients With Heart Failure With Preserved Ejection Fraction
Yasuhiro Izumiya et al.
CANADIAN JOURNAL OF CARDIOLOGY (2014)
Diabetes Mellitus, Prediabetes, and Incidence of Subclinical Myocardial Damage
Elizabeth Selvin et al.
CIRCULATION (2014)
Diabetes-Related Heart Failure - Does Diabetic Cardiomyopathy Exist?
Yasuko K. Bando et al.
CIRCULATION JOURNAL (2014)
Galectin-3 testing: Validity of a novel automated assay in heart failure patients with reduced ejection fraction
D. Gruson et al.
CLINICA CHIMICA ACTA (2014)
Analytical evaluation of the automated galectin-3 assay on the Abbott ARCHITECT immunoassay instruments
David C. Gaze et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Galectin-3 in diabetic patients
Giuseppe Pugliese et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Novel biomarkers in acute heart failure: MR-pro-adrenomedullin
W. Frank Peacock
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Molecular mechanisms of diabetic cardiomyopathy
Heiko Bugger et al.
DIABETOLOGIA (2014)
Galectin-3 in angiogenesis and metastasis
Tatsuyoshi Funasaka et al.
GLYCOBIOLOGY (2014)
Biomarkers of collagen type I metabolism are related to B-type natriuretic peptide, left ventricular size, and diastolic function in heart failure
Johan Lofsjogard et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2014)
Unexpected anti-hypertrophic responses to low-level stimulation of protease-activated receptors in adult rat cardiomyocytes
Anke C. Fender et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis
Jacob A. Udell et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2014)
Correlation of Platelet Reactivity and C-Reactive Protein Levels to Occurrence of Peri-Procedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CRP Study)
Giuseppe Patti et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Biomarkers and diagnostics in heart failure
Hanna K. Gaggin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure Data From CORONA and COACH
A. Rogier van der Velde et al.
CIRCULATION-HEART FAILURE (2013)
Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model
Nazha Hamdani et al.
CIRCULATION-HEART FAILURE (2013)
Performance characteristics of the ARCHITECT Galectin-3 assay
Sonia L. La'ulu et al.
CLINICAL BIOCHEMISTRY (2013)
Galectin-3 in heart failure with preserved ejection fraction
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT
Inder S. Anand et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure
David M. Kaye et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy
Wolfgang Koenig
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Feasibility of using C-reactive protein for point-of-care testing
Ashish Joshi et al.
TECHNOLOGY AND HEALTH CARE (2013)
Troponin T and Plasma Collagen Peptides in Heart Failure
Viorel G. Florea et al.
CIRCULATION-HEART FAILURE (2012)
Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea
Ravi V. Shah et al.
EUROPEAN HEART JOURNAL (2012)
Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial
Tibor Kempf et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice
Pavan K. Battiprolu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Evaluation of Four Rapid Immunochromatographic Tests for the Detection of Cardiac Troponin I
Lovasoa Ramparany et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Midregion Prohormone Adrenomedullin and Prognosis in Patients Presenting With Acute Dyspnea Results From the BACH (Biomarkers in Acute Heart Failure) Trial
Alan Maisel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
A Point-of-Care Platelet Function Assay and C-Reactive Protein for Prediction of Major Cardiovascular Events After Drug-Eluting Stent Implantation
Duk-Woo Park et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Oral rinse MMP-8 point-of-care immuno test identifies patients with strong periodontal inflammatory burden
J. M. Leppilahti et al.
ORAL DISEASES (2011)
Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines
Timo Sorsa et al.
PHARMACOLOGICAL RESEARCH (2011)
Prognostic Value of High-Sensitivity C-Reactive Protein in Heart Failure: A Systematic Review
Jose Paulo Araujo et al.
JOURNAL OF CARDIAC FAILURE (2009)
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
Biao Feng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
CARDIOTROPHIN-1 REVIEW
David Stejskal et al.
BIOMEDICAL PAPERS-OLOMOUC (2008)
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure
Tibor Kempf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and copeptin to predict 1-year mortality in patients with acute destabilized heart failure
Alfons Gegenhuber et al.
JOURNAL OF CARDIAC FAILURE (2007)
Association of high-sensitive C-reactive protein with advanced stage β-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus
Andreas Pfuetzner et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes:: Role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme
LE Wold et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study
E Lubos et al.
EUROPEAN HEART JOURNAL (2006)
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay
NG Morgenthaler et al.
CLINICAL CHEMISTRY (2005)
The association between glucose abnormalities and heart failure in the population-based Reykjavik study
IS Thrainsdottir et al.
DIABETES CARE (2005)
Performance characteristics of four automated natriuretic peptide assays
ML Rawlins et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Harmonization of the Bayer ADVIA Centaur and Abbott AxSYM automated B-type natriuretic peptide assay in patients on hemodialysis
M Barak et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients
J Struck et al.
PEPTIDES (2004)
C-reactive protein
S Black et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA centaur BNP assay
T Mueller et al.
CLINICAL CHEMISTRY (2004)
Analytical and clinical evaluation of the Bayer ADVIA centaur automated B-type natriuretic peptide assay in patients with heart failure: A multisite study
AHB Wu et al.
CLINICAL CHEMISTRY (2004)
B-type natriuretic peptide prevents acute hypertrophic responses in the diabetic rat heart - Importance of cyclic GMP
AC Rosenkranz et al.
DIABETES (2003)
Preclinical diabetic cardiomyopathy: Relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes
P Poirier et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Extracellular signal-regulated kinase and phosphoinositol-3 kinase mediate IGF-1 induced proliferation of fetal sheep cardiomyocytes
NC Sundgren et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: A multicenter evaluation
SJ Wieczorek et al.
AMERICAN HEART JOURNAL (2002)
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
AS Maisel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A rapid troponin-I-based protocol for assessing acute chest pain
NJ Alp et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2001)
In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein
FB Mehrhof et al.
CIRCULATION (2001)
Adrenomedullin: Potential in physiology and pathophysiology
M Jougasaki et al.
LIFE SCIENCES (2000)
分享论文
